Joseph Blasiol, DO
Family Medicine · Topton, PANPI 1124055231
Payments from drug & device makers
Across 509 payments — averaging $17.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- AbbVie$1K
- Novo Nordisk$1K
- Lilly USA, LLC$776
- Merck$718
- Boehringer Ingelheim$717
- plus $2K from 26 others
What the payments were for
- Food & beverage$8,85699%
- Education$621%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 107 | $1,995 |
| AbbVie(2 entities) | 86 | $1,427 |
| Novo Nordisk | 56 | $1,019 |
| Lilly USA, LLC | 48 | $776 |
| Merck | 41 | $718 |
| Boehringer Ingelheim | 37 | $717 |
| Pfizer | 24 | $354 |
| Johnson & Johnson | 20 | $319 |
| GSK | 13 | $223 |
| Sanofi-aventis U.S. LLC | 12 | $186 |
| Amarin Pharma, Inc. | 12 | $175 |
| Biohaven Pharmaceuticals, Inc. | 5 | $127 |
| Xeris Pharmaceuticals, Inc. | 6 | $103 |
| Astellas Pharma US Inc | 4 | $86 |
| Bayer | 5 | $85 |
| Kowa Pharmaceuticals America, Inc. | 6 | $80 |
| Novartis | 4 | $72 |
| Sanofi Pasteur Inc. | 3 | $62 |
| Exact Sciences | 2 | $58 |
| Phathom Pharmaceuticals, Inc. | 2 | $48 |
| Bausch Health US, LLC | 2 | $35 |
| Paratek Pharmaceuticals, Inc. | 2 | $31 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| Pulmonx Corporation | 1 | $29 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $28 |
| Idorsia Pharmaceuticals US Inc | 2 | $28 |
| Scpharmaceuticals Inc. | 1 | $25 |
| Linus Health, Inc. | 1 | $22 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
| Abbott | 1 | $14 |
| Amgen | 1 | $14 |
| Biodelivery Sciences International, Inc. | 1 | $11 |
How this compares
$8,918 in reported general payments places this provider in the 90th percentile of 4,967 family medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 181 | $144,690 |
| JardianceEmpagliflozin | 90 | $98,465 |
| FarxigaDapagliflozin Propanediol | 51 | $58,733 |
| JanuviaSitagliptin Phosphate | 50 | $57,858 |
| XareltoRivaroxaban | 54 | $49,136 |
| OzempicSemaglutide | 41 | $46,373 |
| TrulicityDulaglutide | 26 | $27,539 |
| MounjaroTirzepatide | 21 | $25,227 |
| LinzessLinaclotide | 39 | $24,981 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 17 | $24,889 |
| InvokanaCanagliflozin | 22 | $14,975 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 28 | $13,547 |
| RybelsusSemaglutide | 14 | $13,209 |
| EntrestoSacubitril/Valsartan | 15 | $12,622 |
| Breo ElliptaFluticasone/Vilanterol | 19 | $9,935 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $354 | $144,690181 claims |
| Boehringer IngelheimJardiance, Tradjenta | $717 | $105,178103 claims |
| MerckJanuvia, Janumet Xr | $718 | $82,74667 claims |
| Johnson & JohnsonXarelto, Invokana | $319 | $64,11176 claims |
| Novo NordiskOzempic, Rybelsus | $1,019 | $59,58255 claims |
| AstraZenecaFarxiga | $1,995 | $58,73351 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $776 | $52,76647 claims |
| AbbVieLinzess, Synthroid | $1,427 | $27,55264 claims |
| NovartisEntresto | $72 | $12,62215 claims |
| GSKBreo Ellipta | $223 | $9,93519 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Topton
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Bryce PalchickPittsburgh$4.7M
- Harris CohenHorsham$3.7M
- Shari RozenPittsburgh$2.9M
- Richard CookUniontown$2.1M
- Bruce GebhardtErie$2.1M
- Peter CognettiScranton$1.9M
- Bradley FoxErie$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.